litlas
Log inCreate account

Michael L. Cleary

Active 1981–2024

112
Papers
27,463
Citations
92
h-index
111
i10-index

Citations

Citations per year for Michael L. Cleary1982: 1 citations1983: 6 citations1984: 19 citations1985: 40 citations1986: 55 citations1987: 99 citations1988: 81 citations1989: 91 citations1990: 124 citations1991: 179 citations1992: 150 citations1993: 214 citations1994: 285 citations1995: 210 citations1996: 242 citations1997: 222 citations1998: 179 citations1999: 209 citations2000: 196 citations2001: 220 citations2002: 295 citations2003: 328 citations2004: 321 citations2005: 388 citations2006: 318 citations2007: 303 citations2008: 269 citations2009: 282 citations2010: 349 citations2011: 315 citations2012: 294 citations2013: 197 citations2014: 147 citations2015: 164 citations2016: 142 citations2017: 143 citations2018: 89 citations2019: 422 citations2020: 399 citations2021: 372 citations2022: 288 citations2023: 195 citations2024: 346 citations2025: 147 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,573 citing papers, 41.8% of this breakdownUnited Kingdom: 670 citing papers, 7.9% of this breakdownGermany: 536 citing papers, 6.3% of this breakdownChina: 504 citing papers, 5.9% of this breakdownCanada: 360 citing papers, 4.2% of this breakdownJapan: 318 citing papers, 3.7% of this breakdownFrance: 303 citing papers, 3.6% of this breakdownItaly: 283 citing papers, 3.3% of this breakdownNetherlands: 225 citing papers, 2.6% of this breakdownAustralia: 207 citing papers, 2.4% of this breakdownSwitzerland: 162 citing papers, 1.9% of this breakdownSpain: 131 citing papers, 1.5% of this breakdown
0%41.8%Other 14.9%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology53.9%
  • Medicine38.9%
  • Immunology and Microbiology4.1%
  • Agricultural and Biological Sciences1%
  • Neuroscience1%
  • Engineering0.3%
  • Other0.8%

Topics

  • Epigenetics and DNA Methylation6.3%
  • Acute Myeloid Leukemia Research5.5%
  • Genomics and Chromatin Dynamics5.4%
  • Cancer-related gene regulation3.9%
  • Lymphoma Diagnosis and Treatment2.8%
  • Protein Degradation and Inhibitors2.7%
  • Other73.4%

Coauthors

All papers

Open in search
  1. Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants

    Authors: Nicole L. Welch, Meilin Zhu, Catherine Hua, Juliane Weller, Marzieh Ezzaty Mirhashemi, Tien G. Nguyen, Sreekar Mantena, Matthew R. Bauer, Bennett Shaw, Cheri M. Ackerman, Sri Gowtham Thakku, Megan W. Tse, Jared Kehe, Marie-Martine Uwera, Jacqueline S. Eversley, Derek A. Bielwaski, Graham McGrath, Joseph Braidt, Jeremy Johnson, Felecia Cerrato, Gage K. Moreno, Lydia A. Krasilnikova, Brittany A. Petros, Gabrielle Gionet, Ewa King, Richard C. Huard, Samantha Jalbert, Michael L. Cleary, Nicholas FitzGerald, Stacey Gabriel, Glen R. Gallagher, Sandra Smole, Lawrence C. Madoff, Catherine Brown, Matthew W. Keller, Malania M. Wilson, Marie K. Kirby, John Barnes, Daniel J. Park, Katherine J. Siddle, Christian Happi, Deborah T. Hung, Michael Springer, Bronwyn MacInnis, Jacob E. Lemieux, Eric Rosenberg, John A. Branda, Paul C. Blainey, Pardis C. Sabeti, Cameron Myhrvold - Nature Medicine 2022 cited by 303

  2. The Menin Tumor Suppressor Protein Is an Essential Oncogenic Cofactor for MLL-Associated Leukemogenesis

    Authors: Akihiko Yokoyama, Tim C. P. Somervaille, Kevin S. Smith, Orit Rozenblatt–Rosen, Matthew Meyerson, Michael L. Cleary - Cell 2005 cited by 685

  3. Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes

    Authors: Akihiko Yokoyama, Michael L. Cleary - Cancer Cell 2008 cited by 542

  4. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia

    Authors: Tim C. P. Somervaille, Michael L. Cleary - Cancer Cell 2006 cited by 591

  5. Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells

    Authors: Tim C. P. Somervaille, Christina Matheny, Gary J. Spencer, Masayuki Iwasaki, John L. Rinn, Daniela Witten, Howard Y. Chang, Sheila Shurtleff, James R. Downing, Michael L. Cleary - Cell stem cell 2009 cited by 359

  6. A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription

    Authors: Akihiko Yokoyama, Min Lin, Alpana Naresh, Issay Kitabayashi, Michael L. Cleary - Cancer Cell 2010 cited by 371

  7. Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression

    Authors: Akihiko Yokoyama, Zhong Wang, Joanna Wysocka, Mrinmoy Sanyal, Deborah J. Aufiero, Issay Kitabayashi, Winship Herr, Michael L. Cleary - Molecular and Cellular Biology 2004 cited by 644

  8. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9

    Authors: Paul M. Ayton, Michael L. Cleary - Genes & Development 2003 cited by 443

  9. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia

    Authors: Masayuki Iwasaki, Michaela Liedtke, Andrew J. Gentles, Michael L. Cleary - Cell stem cell 2015 cited by 125

  10. CREB Binding Protein Interacts with Nucleoporin-Specific FG Repeats That Activate Transcription and Mediate NUP98-HOXA9 Oncogenicity

    Authors: Lawryn H. Kasper, Paul K. Brindle, Catherine A. Schnabel, Colin E.J. Pritchard, Michael L. Cleary, Jan M. A. van Deursen - Molecular and Cellular Biology 1999 cited by 323

  11. Pbx1 Regulates Self-Renewal of Long-Term Hematopoietic Stem Cells by Maintaining Their Quiescence

    Authors: Francesca Ficara, Mark Murphy, Min Lin, Michael L. Cleary - Cell stem cell 2008 cited by 242

  12. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia

    Authors: Li Zhu, Qin Li, Stephen H.K. Wong, Min Huang, Brianna J. Klein, Jinfeng Shen, Larissa Ikenouye, Masayuki Onishi, Dominik Schneidawind, Corina Buechele, Loren Hansen, Jesús Duque‐Afonso, Fangfang Zhu, Glòria Mas Martín, Or Gozani, Ravindra Majeti, Tatiana G. Kutateladze, Michael L. Cleary - Cancer Discovery 2016 cited by 160

  13. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias

    Authors: Douglas Tkachuk, Sabine Köhler, Michael L. Cleary - Cell 1992 cited by 935

  14. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP

    Authors: Kenji Deguchi, Paul M. Ayton, Melina Carapeti, Jeffery L. Kutok, Cynthia S. Snyder, Ifor R. Williams, Nicholas C.P. Cross, Christopher K. Glass, Michael L. Cleary, D. Gary Gilliland - Cancer Cell 2003 cited by 224

  15. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus

    Authors: Seung K. Kim, Licia Selleri, Joon S. Lee, Andrew Y. Zhang, Xueying Gu, Yakop Jacobs, Michael L. Cleary - Nature Genetics 2002 cited by 209

  16. Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells

    Authors: Feng Pan, Masayuki Iwasaki, Wenqi Wu, Yanan Jiang, Xin Yang, Li Zhu, Zhigang Zhao, Michael L. Cleary - Blood Advances 2023 cited by 17

  17. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

    Authors: Michael L. Cleary, Stephen D. Smith, Jeffrey Sklar - Cell 1986 cited by 1,228

  18. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors

    Authors: Antonio Cozzio, Emmanuelle Passegué, Paul M. Ayton, Holger Karsunky, Michael L. Cleary, Irving L. Weissman - Genes & Development 2003 cited by 662

  19. Requirement forPbx1in skeletal patterning and programming chondrocyte proliferation and differentiation

    Authors: Licia Selleri, Michael J. Depew, Yakop Jacobs, Sumit K. Chanda, Kwok Yeung Tsang, Kathryn S.E. Cheah, John L.R. Rubenstein, Stephen O’Gorman, Michael L. Cleary - Development 2001 cited by 296

  20. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

    Authors: Paul M. Ayton, Michael L. Cleary - Oncogene 2001 cited by 503

  21. Pbx/Meis Deficiencies Demonstrate Multigenetic Origins of Congenital Heart Disease

    Authors: Kryn Stankunas, Ching Shang, Karen Y. Twu, Shih-Chu Kao, Nancy A. Jenkins, Neal G. Copeland, Mrinmoy Sanyal, Licia Selleri, Michael L. Cleary, Ching-Pin Chang - Circulation Research 2008 cited by 156

  22. The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential

    Authors: Stephen H.K. Wong, David L. Goode, Masayuki Iwasaki, Michael C. Wei, Hsu-Ping Kuo, Li Zhu, Dominik Schneidawind, Jesús Duque‐Afonso, Ziming Weng, Michael L. Cleary - Cancer Cell 2015 cited by 144

  23. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver

    Authors: Jorge DiMartino, Licia Selleri, David Traver, Meri T. Firpo, Joon Whan Rhee, Roger A. Warnke, Stephen O’Gorman, Irving L. Weissman, Michael L. Cleary - Blood 2001 cited by 172

  24. The TALE Homeodomain Protein Pbx2 Is Not Essential for Development and Long-Term Survival

    Authors: Licia Selleri, Jorge DiMartino, Jan van Deursen, Andrea Brendolan, Mrinmoy Sanyal, Elles M. J. Boon, Terence D. Capellini, Kevin S. Smith, Joon Whan Rhee, Heike Pöpperl, Gerard C. Grosveld, Michael L. Cleary - Molecular and Cellular Biology 2004 cited by 93